CJC-1295 DAC
A GHRH analog with an albumin-binding Drug Affinity Complex for extended half-life.
Research Overview
CJC-1295 with DAC is a modified GHRH(1-29) analog bearing a Drug Affinity Complex (DAC) that binds serum albumin, substantially extending its circulating half-life in research models compared with the no-DAC version.
As a GHRH-receptor agonist it is studied for sustained stimulation of the growth-hormone axis.
Specifications
| Compound | CJC-1295 DAC (CJC-1295 with DAC) |
| Classification | Endocrine research compound |
| Molecular weight | 3,647.2 g/mol |
| Sequence / Form | Modified GRF(1-29) + Drug Affinity Complex |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
